|
?:authorAffiliation
|
-
[\'Toronto Centre for Liver Disease, University of Toronto, Toronto, ON, Canada; University Health Network, University of Toronto, Toronto, ON, Canada. Electronic address: jordan.feld@uhn.ca.\', \'Faculty of Medicine, University of Toronto, Toronto, ON, Canada.\', \'Toronto Centre for Liver Disease, University of Toronto, Toronto, ON, Canada; University Health Network, University of Toronto, Toronto, ON, Canada.\', \'Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.\', \'University Health Network, University of Toronto, Toronto, ON, Canada.\', \'Division of Infectious Diseases, William Osler Health System and McMaster University, Hamilton, ON, Canada.\', \'Michael Garron Hospital, University of Toronto, Toronto, ON, Canada.\', \'St Michael\'s Hospital, University of Toronto, Toronto, ON, Canada.\', \'Trillium Health Partners, Toronto, ON, Canada.\', \'Toronto General Hospital, Multiorgan Transplant Centre, University of Toronto, Toronto, ON, Canada.\', \'North York General Hospital, University of Toronto, Toronto, ON, Canada.\', \'Eiger BioPharmaceuticals, Palo Alto, CA, USA.\', \'The Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada.\', \'Departments of Medicine and Microbiology & Immunology, Stanford University School of Medicine, Palo Alto, CA, USA.\', \'Toronto Centre for Liver Disease, University of Toronto, Toronto, ON, Canada; University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}